Ranbaxy's US FDA case may hurt other Indian pharmas

Ranbaxy's US FDA case may hurt other Indian pharmas Ranbaxy-Daiichi Sankyo is still good despite the co's trouble with US laws. ...
03:47 AM, Sep 18, 2008
ibn apps